{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:08:33Z","timestamp":1793196513266,"version":"4.5.0"},"reference-count":181,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.rgmxen.2025.12.001","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T12:39:04Z","timestamp":1766147944000},"page":"89-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Fifth Mexican consensus on the diagnosis and treatment of Helicobacter pylori infection"],"prefix":"10.1016","volume":"91","author":[{"given":"J.M.","family":"Remes-Troche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bosques-Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.D.","family":"Cano-Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Velarde-Ruiz Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.V.","family":"Bielsa-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Camorlinga Ponce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Coss-Adame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Esquivel-Ayanegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.R.","family":"Flores-Rend\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"G\u00f3mez-Escudero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Gonz\u00e1lez-Huezo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Higuera-de-la-Tijera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.A.","family":"Leal-Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"L\u00f3pez-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.C.","family":"Morel-Cerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Noble-Lugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Xochiquetzal Ortiz-Olvera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ra\u00f1a-Garibay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Riquelme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Tanimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.E.","family":"Trujillo-Ben\u00e1vides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.F.","family":"Uscanga-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"Amezcua-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.R.","family":"Valdovinos-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rgmxen.2025.12.001_bib0005","first-page":"325","article-title":"IV consenso mexicano sobre Helicobacter pylori","volume":"83","author":"Bosques-Padilla","year":"2018","journal-title":"Rev Gastroenterol Mex"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0010","series-title":"The OPGE supports the Latin American Registry of Helicobacter pylori (HP-Latam Reg)","year":"2025"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0015","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/ueg2.12605","article-title":"Quadruple therapies show a higher eradication rate compared to standard triple therapy for Helicobacter pylori infection within the LEGACy consortium. A multicenter observational study in European and Latin American countries","volume":"12","author":"Medel-Jara","year":"2024","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0020","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2105\/AJPH.74.9.979","article-title":"Consensus methods: characteristics and guidelines for use","volume":"74","author":"Fink","year":"1984","journal-title":"Am J Public Health."},{"issue":"7650","key":"10.1016\/j.rgmxen.2025.12.001_bib0025","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0030","first-page":"417","article-title":"Sistema GRADE para clasificar nivel de evidencia y grado de las recomendaciones para la elaboraci\u00f3n de gu\u00edas de buena pr\u00e1ctica cl\u00ednica","volume":"77","author":"O\u00f1ate-Oca\u00f1a","year":"2009","journal-title":"Cir Cir"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0035","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1053\/j.gastro.2023.12.022","article-title":"Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022","volume":"166","author":"Chen","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0040","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S2468-1253(23)00070-5","article-title":"Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis","volume":"8","author":"Li","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0045","doi-asserted-by":"crossref","first-page":"11221","DOI":"10.3748\/wjg.v21.i40.11221","article-title":"Diagnosis of Helicobacter pylori infection: current options and developments","volume":"21","author":"Wang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0050","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2166\/wh.2009.070","article-title":"Transmission of Helicobacter pylori and the role of water and biofilms","volume":"7","author":"Percival","year":"2009","journal-title":"J Water Health"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/5584_2019_357","article-title":"Epidemiology, diagnosis and risk factors of Helicobacter pylori infection","volume":"1149","author":"Kotilea","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.47892\/rgp.2024.441.1624","article-title":"Reducci\u00f3n de la infecci\u00f3n por Helicobacter pylori en pacientes derivados a endoscopia digestiva alta en Santiago de Chile entre 2010-2020","volume":"44","author":"Silva","year":"2024","journal-title":"Rev Gastroenterol del Per\u00fa"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0065","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4253\/wjge.v16.i9.526","article-title":"Prevalence and resistance of Helicobacter pylori in a predominantly Hispanic population","volume":"16","author":"Tabesh","year":"2024","journal-title":"World J Gastrointest Endosc"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0070","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/515663","article-title":"A community-based seroepidemiologic study of Helicobacter pylori infection in Mexico","volume":"178","author":"Torres","year":"1998","journal-title":"J Infect Dis."},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0075","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1017\/S0950268818000857","article-title":"Force of infection of Helicobacter pylori in Mexico: evidence from a national survey using a hierarchical Bayesian model","volume":"146","author":"Alarid-Escudero","year":"2018","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0080","first-page":"209","article-title":"Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701)","volume":"24","author":"Porras","year":"2013","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0085","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.11546","article-title":"Helicobacter pylori prevalence in healthy Mexican children: comparison between two non-invasive methods","volume":"9","author":"Mart\u00ednez-Santos","year":"2021","journal-title":"PeerJ"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0090","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1744-313X.2010.00932.x","article-title":"Genetic risk factors for inflammatory bowel disease in a North\u2010eastern Mexican population","volume":"37","author":"Garza\u2010Gonz\u00e1lez","year":"2010","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0095","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.4317\/medoral.16.e175","article-title":"vacA genotypes in oral cavity and Helicobacter pylori seropositivity among adults without dyspepsia","volume":"16","author":"Fernandez-Tilapa","year":"2011","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0100","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/MPG.0b013e318248877f","article-title":"Natural history of Helicobacter pylori Infection in Mexican schoolchildren: incidence and spontaneous clearance","volume":"55","author":"Duque","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0105","doi-asserted-by":"crossref","DOI":"10.3390\/nu11122922","article-title":"Low Serum B12 concentrations are associated with low B12 dietary intake but not with Helicobacter pylori infection or abnormal gastric function in rural Mexican women","volume":"11","author":"Anaya-Loyola","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0110","first-page":"227","article-title":"Seroepidemiology of Helicobacter pylori infection in a Mennonite community in Durango State, Mexico","volume":"6","author":"Alvarado\u2010Esquivel","year":"2014","journal-title":"Gastroenterology Res"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0115","first-page":"110","article-title":"Recurrence of infection and diversity of Helicobacter pylori strains in an adult population in Mexico treated with empirical standard triple therapy","author":"S\u00e1nchez Cu\u00e9n","year":"2017","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0120","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1111\/j.1572-0241.2003.07708.x","article-title":"High rates of recurrence and of transient reinfections of Helicobacter pylori in a population with high prevalence of infection","volume":"98","author":"Leal-Herrera","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0125","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2025-335523","article-title":"Helicobacter pylori antibiotic resistance: a global challenge in search of solutions","author":"Schulz","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0130","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1128\/JCM.39.7.2677-2680.2001","article-title":"Increasing multidrug resistance in Helicobacter pylori strains isolated from children and adults in Mexico","volume":"39","author":"Torres","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0135","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.539115","article-title":"Phenotypic and genotypic antibiotic resistance patterns in Helicobacter pylori strains from ethnically diverse population in M\u00e9xico","volume":"10","author":"Camorlinga-Ponce","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib1530","doi-asserted-by":"crossref","first-page":"S928","DOI":"10.1016\/S0016-5085(25)03069-0","article-title":"Su2008: Study of antimicrobial resistance in Helicobacter pylori based on molecular test by next generation sequencing in Latin American countries","volume":"169","author":"Latorre","year":"2025","journal-title":"Gastroenterol."},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2008.11.016","article-title":"Helicobacter pylori virulence factors in gastric carcinogenesis","volume":"282","author":"Wen","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0145","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3390\/pathogens12020234","article-title":"Helicobacter pylori virulence factors and clarithromycin resistance-associated mutations in Mexican patients","volume":"12","author":"Alarc\u00f3n-Mill\u00e1n","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0150","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.meegid.2016.06.044","article-title":"Clarithromycin resistance and prevalence of Helicobacter pylori virulent genotypes in patients from Southern M\u00e9xico with chronic gastritis","volume":"44","author":"Alarc\u00f3n-Mill\u00e1n","year":"2016","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0155","first-page":"220","article-title":"Helicobacter pylori vacA and cagA genotype diversity and interferon gamma expression in patients with chronic gastritis and patients with gastric cancer","volume":"79","author":"Mart\u00ednez-Carrillo","year":"2014","journal-title":"Rev Gastroenterol Mex (Engl Ed)"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0160","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13099-019-0286-9","article-title":"CagL polymorphisms D58\/K59 are predominant in Helicobacter pylori strains isolated from Mexican patients with chronic gastritis","volume":"11","author":"Rom\u00e1n-Rom\u00e1n","year":"2019","journal-title":"Gut Pathog"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0165","first-page":"404","article-title":"Asociaci\u00f3n de cepas de Helicobater pylori cagA+ con alta actividad de ureasa y dispepsia en adultos Mexicanos","volume":"85","author":"Moreno-Ochoa","year":"2020","journal-title":"Rev Gastroenterol Mex"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0170","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003840.pub4","article-title":"Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients","author":"Ford","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0175","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jss.2012.10.046","article-title":"Eradication of Helicobacter pylori for prevention of ulcer recurrence after simple closure of perforated peptic ulcer: a meta-analysis of randomized controlled trials","volume":"182","author":"Wong","year":"2013","journal-title":"J Surg Res"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0180","first-page":"19","article-title":"Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse","volume":"55","author":"Labenz","year":"1994","journal-title":"Digestion"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0185","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00000658-200002000-00001","article-title":"Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation","volume":"231","author":"Ng","year":"2000","journal-title":"Ann Surg"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0190","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-3-642-57054-4_16","article-title":"Eradication of Helicobacter pylori and stability of remissions in low-grade gastric B-cell lymphomas of the MALT: results of an ongoing multicenter trial","volume":"156","author":"Thiede","year":"2000","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0195","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cgh.2009.07.017","article-title":"Effects of Helicobacter pylori eradication on early stage gastric MALT lymphoma","volume":"8","author":"Zullo","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0200","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/ajg.2009.314","article-title":"Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: a pooled data analysis","volume":"104","author":"Zullo","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0205","first-page":"37","article-title":"Effect of Helicobacter pylori eradication therapy on the response of MALT-Gastric lymphoma","volume":"100","author":"Dabbebi","year":"2022","journal-title":"Tunis Med"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0210","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.3748\/wjg.v29.i14.2202","article-title":"Effectiveness of Helicobacter pylori eradication in the treatment of early-stage gastric MALT lymphoma: an up-to-date meta-analysis","volume":"29","author":"Bueno Lemos","year":"2023","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0215","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MCG.0b013e31829f2e25","article-title":"Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia","volume":"48","author":"Zhao","year":"2014","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0220","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.3748\/wjg.v22.i12.3486","article-title":"Helicobacter pylori eradication therapy for functional dyspepsia: systematic review and meta-analysis","volume":"22","author":"Du","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0225","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1157\/13072839","article-title":"Efecto del tratamiento erradicador en pacientes con dispepsia funcional e infecci\u00f3n por Helicobacter pylori: ensayo cl\u00ednico aleatorizado frente a placebo","volume":"124","author":"Ruiz Garc\u00eda","year":"2005","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0230","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1001\/archinternmed.2011.533","article-title":"Helicobacter pylori eradication in functional dyspepsia: HEROES trial","volume":"171","author":"Mazzoleni","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0235","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5056\/jnm.2013.19.2.233","article-title":"Effect of eradication on functional dyspepsia","volume":"19","author":"Kim","year":"2013","journal-title":"J Neurogastroenterol Motil"},{"issue":"S19","key":"10.1016\/j.rgmxen.2025.12.001_bib0240","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s00535-008-2259-5","article-title":"Helicobacter pylori and NSAID-induced gastric ulcer in a Japanese population","volume":"44","author":"Murakami","year":"2009","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0245","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8101722","article-title":"Risk of recurrent peptic ulcer disease in patients receiving cumulative defined daily dose of nonsteroidal anti-inflammatory drugs","volume":"8","author":"Liang","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0250","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5009\/gnl14372","article-title":"Does Helicobacter pylori exacerbate gastric mucosal injury in users of nonsteroidal anti-inflammatory drugs? A multicenter, retrospective, case-control study","volume":"10","author":"Kono","year":"2016","journal-title":"Gut Liver"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0255","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0016-5085(99)70120-4","article-title":"Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers","volume":"116","author":"Taha","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0260","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1053\/bega.1999.0066","article-title":"How does Helicobacter pylori infection interact with non-steroidal anti-inflammatory drugs?","volume":"14","author":"Chan","year":"2000","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"9083","key":"10.1016\/j.rgmxen.2025.12.001_bib0265","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0140-6736(97)04523-6","article-title":"Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers","volume":"350","author":"Chan","year":"1997","journal-title":"Lancet"},{"issue":"9300","key":"10.1016\/j.rgmxen.2025.12.001_bib0270","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(02)07272-0","article-title":"Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial","volume":"359","author":"Chan","year":"2002","journal-title":"The Lancet"},{"issue":"9133","key":"10.1016\/j.rgmxen.2025.12.001_bib0275","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(98)04206-8","article-title":"Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study","volume":"352","author":"Hawkey","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0280","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bcmd.2006.10.001","article-title":"Hepcidin mimetics from microorganisms? A possible explanation for the effect of Helicobacter pylori on iron homeostasis","volume":"38","author":"Beutler","year":"2007","journal-title":"Blood Cells Mol Dis."},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0285","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1083-4389.2002.00073.x","article-title":"Helicobacter pylori\u2010related iron deficiency anemia: a review","volume":"7","author":"Barabino","year":"2002","journal-title":"Helicobacter"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0290","first-page":"165","article-title":"Is hepcidin the bridge linking Helicobacter pylori and anemia of chronic infection? A research proposal","volume":"46","author":"Pellicano","year":"2004","journal-title":"Panminerva Med"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0295","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0016-5085(98)70192-1","article-title":"Serum ferritin, hemoglobin, and Helicobacter pylori infection: a seroepidemiologic survey comprising 2794 Danish adults","volume":"115","author":"Milman","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0300","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3390\/children9091324","article-title":"The relationship between anemia and Helicobacter Pylori infection in children","volume":"9","author":"Lupu","year":"2022","journal-title":"Children"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0305","first-page":"313","article-title":"Improvement of complete blood count in patients with iron deficiency anemia and Helicobacter pylori infection after the eradication of Helicobacter pylori","volume":"51","author":"Hacihanefioglu","year":"2004","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0310","first-page":"2939","article-title":"Helicobacter pylori eradication shifts monocyte Fc\u03b3 receptor balance toward inhibitory Fc\u03b3RIIB in immune thrombocytopenic purpura patients","volume":"118","author":"Asahi","year":"2008","journal-title":"Journal of J Clin Invest"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0315","article-title":"Helicobacter pylori infection and idiopathic thrombocytopenic purpura: description of 21 newly diagnosed cases","volume":"89","author":"Veneri","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0320","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00277-008-0667-5","article-title":"Long-term efficacy of Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura: 7-year follow-up prospective study","volume":"88","author":"Tsumoto","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0325","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1182\/blood-2003-03-0900","article-title":"Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura?","volume":"103","author":"Michel","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0330","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1442-200x.2005.02058.x","article-title":"Helicobacter pylori infection in children with chronic idiopathic thrombocytopenic purpura","volume":"47","author":"Hayashi","year":"2005","journal-title":"Pediatr Int"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0335","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","article-title":"Helicobacter pylori infection","volume":"9","author":"Malfertheiner","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0340","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2024.12.033","article-title":"Eradication therapy to prevent gastric cancer in Helicobacter pylori\u2013positive individuals: systematic review and meta-analysis of randomized controlled trials and observational studies","volume":"169","author":"Ford","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0345","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/MCG.0000000000001195","article-title":"Does Helicobacter pylori eradication reduce the incidence of metachronous gastric cancer after curative endoscopic resection of early gastric cancer","volume":"54","author":"Zhao","year":"2020","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0350","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/j.gastro.2022.03.039","article-title":"Effect of Helicobacter pylori eradication on gastric cancer prevention: updated report from a randomized controlled trial with 26.5 years of follow-up","volume":"163","author":"Yan","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0355","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa1909666","article-title":"Family history of gastric cancer and Helicobacter pylori treatment","volume":"382","author":"Choi","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0360","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/ajco.13704","article-title":"Screening and surveillance for gastric cancer: does family history play an important role in shaping our strategy?","volume":"18","author":"Luu","year":"2022","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0365","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1136\/gutjnl-2020-322368","article-title":"Screening and eradication of Helicobacter pylori or gastric cancer prevention: the Taipei global consensus","volume":"69","author":"Liou","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0370","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1053\/j.gastro.2024.11.001","article-title":"AGA clinical practice update on screening and surveillance in individuals at increased risk for gastric cancer in the United States: expert review","volume":"168","author":"Shah","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0375","doi-asserted-by":"crossref","first-page":"709","DOI":"10.14309\/ajg.0000000000003350","article-title":"ACG clinical guideline: diagnosis and management of gastric premalignant conditions","volume":"120","author":"Morgan","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0385","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1053\/j.gastro.2019.12.002","article-title":"AGA technical review on gastric intestinal metaplasia\u2014epidemiology and risk factors","volume":"158","author":"Altayar","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0390","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","article-title":"Classification and grading of gastritis","volume":"20","author":"Dixon","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0395","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.humpath.2004.12.008","article-title":"Staging and grading of chronic gastritis","volume":"36","author":"Rugge","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0400","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.gie.2009.12.029","article-title":"The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis","volume":"71","author":"Capelle","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0405","doi-asserted-by":"crossref","DOI":"10.1111\/hel.13013","article-title":"Effect of Helicobacter pylori eradication on gastric precancerous lesions: a systematic review and meta\u2010analysis","volume":"28","author":"Zhu","year":"2023","journal-title":"Helicobacter"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0410","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1053\/j.gastro.2020.11.017","article-title":"The Colombian chemoprevention trial: 20-year follow-up of a cohort of patients with gastric precancerous lesions","volume":"160","author":"Piazuelo","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0415","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1158\/1055-9965.EPI-03-0124","article-title":"Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial","volume":"13","author":"Ley","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prevent"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0420","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/gutjnl-2021-324057","article-title":"Severity of gastric intestinal metaplasia predicts the risk of gastric cancer: a prospective multicentre cohort study (GCEP)","volume":"71","author":"Lee","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0425","first-page":"1401","article-title":"Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety","volume":"90","author":"Kuipers","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0430","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/apt.13324","article-title":"Systematic review: the effects of long\u2010term proton pump inhibitor use on serum gastrin levels and gastric histology","volume":"42","author":"Lundell","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0435","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.cgh.2016.05.018","article-title":"Use of proton pump inhibitors and risks of fundic gland polyps and gastric cancer: systematic review and meta-analysis","volume":"14","author":"Tran-Duy","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0440","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/gut.2010.207662","article-title":"Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori","volume":"60","author":"Hagiwara","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0445","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/gutjnl-2017-314605","article-title":"Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study","volume":"67","author":"Cheung","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0450","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1111\/jgh.14759","article-title":"Relationship between long\u2010term use of proton pump inhibitors and risk of gastric cancer: a systematic analysis","volume":"34","author":"Jiang","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0455","first-page":"111","article-title":"Recomendaciones de buena pr\u00e1ctica cl\u00ednica en la prescripci\u00f3n y deprescripci\u00f3n de inhibidores de la bomba de protones. Revisi\u00f3n por expertos de la AMG","volume":"90","author":"Valdovinos-Garc\u00eda","year":"2025","journal-title":"Rev Gastroenterol Mex"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0460","doi-asserted-by":"crossref","first-page":"366","DOI":"10.5009\/gnl210202","article-title":"The incidence and risk factors for metachronous gastric cancer in the remnant stomach after gastric cancer surgery","volume":"16","author":"Choi","year":"2022","journal-title":"Gut Liver"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0465","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/jep.13179","article-title":"Effects of eradicating Helicobacter pylori on metachronous gastric cancer prevention: a systematic review and meta\u2010analysis","volume":"26","author":"Fan","year":"2020","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0470","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/MEG.0000000000001740","article-title":"Effectiveness of Helicobacter pylori eradication in preventing metachronous gastric cancer and preneoplastic lesions. A systematic review and meta-analysis","volume":"32","author":"Khan","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0475","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7861\/clinmedicine.14-2-165","article-title":"The newer direct oral anticoagulants: a practical guide","volume":"14","author":"Thachil","year":"2014","journal-title":"Clin Med"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0480","article-title":"Gastrointestinal hemorrhage in warfarin anticoagulated patients: incidence, risk factor, management, and outcome","volume":"2014","author":"Chen","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0485","doi-asserted-by":"crossref","first-page":"h1857","DOI":"10.1136\/bmj.h1857","article-title":"Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study","volume":"350","author":"Abraham","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0490","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2018.17242","article-title":"Association of oral anticoagulants and proton pump inhibitor cotherapy with hospitalization for upper gastrointestinal tract bleeding","volume":"320","author":"Ray","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0495","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1053\/j.gastro.2016.08.054","article-title":"Association of proton pump inhibitors with reduced risk of warfarin-related serious upper gastrointestinal bleeding","volume":"151","author":"Ray","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0500","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/apt.14652","article-title":"Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti\u2010inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors","volume":"47","author":"Venerito","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0505","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v23.i11.1954","article-title":"Gastrointestinal bleeding in patients on novel oral anticoagulants: risk, prevention and management","volume":"23","author":"Cheung","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0510","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cgh.2011.12.036","article-title":"Helicobacter pylori infection is strongly associated with gastric and duodenal ulcers in a large prospective study","volume":"10","author":"Sch\u00f6ttker","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0515","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00535-021-01769-0","article-title":"Evidence-based clinical practice guidelines for peptic ulcer disease 2020","volume":"56","author":"Kamada","year":"2021","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0520","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/jgh.12805","article-title":"Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti\u2010inflammatory drugs, low\u2010dose aspirin, and antihypertensive drugs: a case\u2010control study","volume":"30","author":"Nagata","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0525","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/ajg.2015.98","article-title":"Peptic ulcer bleeding risk. The role of Helicobacter pylori infection in NSAID\/low-dose aspirin users","volume":"110","author":"Sostres","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0530","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/gutjnl-2019-318715","article-title":"Prevention of recurrent idiopathic gastroduodenal ulcer bleeding: a double-blind, randomised trial","volume":"69","author":"Wong","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0535","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2036.2004.01898.x","article-title":"Helicobacter pylori eradication therapy vs. antisecretory non\u2010eradication therapy for the prevention of recurrent bleeding from peptic ulcer","volume":"19","author":"Gisbert","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0540","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1136\/gutjnl-2022-327745","article-title":"Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report","volume":"71","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0545","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13017-019-0283-9","article-title":"Perforated and bleeding peptic ulcer: WSES guidelines","volume":"15","author":"Tarasconi","year":"2020","journal-title":"World J Emerg Surg"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0550","first-page":"346","article-title":"Helicobacter pylori eradication within 120 days is associated with decreased complicated recurrent peptic ulcers in peptic ulcer bleeding patients","volume":"9","author":"Chang","year":"2014","journal-title":"Gut Liver"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0555","doi-asserted-by":"crossref","first-page":"618","DOI":"10.21037\/tp-23-155","article-title":"Analysis of risk factors for ulcer recurrence and upper gastrointestinal bleeding in children with peptic ulcer treated with Helicobacter pylori eradication therapy","volume":"12","author":"Li","year":"2023","journal-title":"Transl Pediatr"},{"issue":"Suppl 1","key":"10.1016\/j.rgmxen.2025.12.001_bib0560","article-title":"Latin American and the Caribbean Code against cancer 1st edition: infections and cancer","volume":"86","author":"Herrero","year":"2023","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0565","first-page":"1","article-title":"Schistosomes, liver flukes and Helicobacter pylori","volume":"61","year":"1994","journal-title":"IARC Monogr Eval Carcinog Risks Hum."},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0570","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.3390\/ijms24032895","article-title":"Helicobacter pylori and gastric cancer: pathogenetic mechanisms","volume":"24","author":"Salvatori","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0575","doi-asserted-by":"crossref","first-page":"765","DOI":"10.14309\/ajg.0000000000003301","article-title":"Gastric cancer screening in the United States: a review of current evidence, challenges, and future perspectives","volume":"120","author":"Li","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0580","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5152\/tjg.2017.16","article-title":"Gastroesophageal reflux disease and the relationship with Helicobacter pylori","volume":"28","author":"Mungan","year":"2017","journal-title":"Turkish J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0585","doi-asserted-by":"crossref","first-page":"423","DOI":"10.5114\/pg.2024.145379","article-title":"Relationship between Helicobacter pylori infection and gastroesophageal reflux disease","volume":"19","author":"Y\u0131lmaz","year":"2024","journal-title":"Gastroenterol Rev"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0590","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000536443","article-title":"Relationship between Helicobacter pylori eradication and Barrett\u2019s esophagus elongation","volume":"105","author":"Hashigami","year":"2024","journal-title":"Digestion"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0600","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11081305","article-title":"Diagnosis of Helicobacter pylori infection and recent advances","volume":"11","author":"Yang","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0605","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11081458","article-title":"Current Helicobacter pylori diagnostics","volume":"11","author":"Bordin","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0610","first-page":"532","article-title":"Consensus recommendations for the screening, diagnosis, and management of Helicobacter pylori infection in Hong Kong","volume":"29","author":"Leung","year":"2023","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0615","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000538349","article-title":"Diagnostic methods for Helicobacter pylori","volume":"33","author":"Costa","year":"2024","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0620","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection-the Maastricht IV\/ Florence Consensus Report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0625","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3390\/antibiotics13040357","article-title":"Change in diagnosis of Helicobacter pylori infection in the treatment-failure era","volume":"13","author":"Spagnuolo","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0630","doi-asserted-by":"crossref","first-page":"148","DOI":"10.15430\/JCP.24.024","article-title":"Comparison of GastroPanel\u00ae and GENEDIA\u00ae in diagnosing Helicobacter pylori infection and gastric lesions","volume":"29","author":"Choi","year":"2024","journal-title":"J Cancer Prev"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0640","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.3748\/wjg.v26.i26.3834","article-title":"Helicobacter pylori-induced inflammation masks the underlying presence of low-grade dysplasia on gastric lesions","volume":"26","author":"Panarese","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0645","article-title":"A comparison between histology and rapid urease test in the diagnosis of helicobacter pylori in gastric biopsies: a systematic review","volume":"15","author":"Urgessa","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0650","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","article-title":"Kyoto global consensus report on Helicobacter pylori gastritis","volume":"64","author":"Sugano","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0655","first-page":"207","article-title":"Increased detection of premalignant gastric lesions through Sydney protocol in comparison with non-protocolized gastric biopsies","volume":"27","author":"Gonzalo-Latorre","year":"2016","journal-title":"Gastroenterol latinoam"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0660","doi-asserted-by":"crossref","first-page":"86","DOI":"10.47892\/rgp.2022.422.1377","article-title":"Patrones de detecci\u00f3n de Helicobacter pylori y lesiones relacionadas mediante protocolo S\u00eddney en una poblaci\u00f3n de Antioquia, Colombia","volume":"42","author":"S\u00e1nchez-Londo\u00f1o","year":"2022","journal-title":"Rev Gastroenterol Peru"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0665","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.4067\/S0034-98872014000900013","article-title":"Diagn\u00f3stico precoz de c\u00e1ncer g\u00e1strico: Propuesta de detecci\u00f3n y seguimiento de lesiones premalignas g\u00e1stricas: protocolo ACHED","volume":"142","author":"Roll\u00e1n","year":"2014","journal-title":"Rev Med Chil"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0670","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/den.13808","article-title":"Regular arrangement of collecting venules and the Kimura-Takemoto classification for the endoscopic diagnosis of Helicobacter pylori infection: evaluation in a Western setting","volume":"33","author":"Ebigbo","year":"2021","journal-title":"Dig Endosc"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0675","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/den.13540","article-title":"Can image-enhanced endoscopy improve the diagnosis of Kyoto classification of gastritis in the clinical setting?","volume":"32","author":"Dohi","year":"2020","journal-title":"Dig Endosc"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0680","doi-asserted-by":"crossref","first-page":"1","DOI":"10.37126\/aige.v4.i1.1","article-title":"Kyoto classification of gastritis, virtual chromoendoscopy and artificial intelligence: where are we going? What do we need?","volume":"4","author":"Panarese","year":"2023","journal-title":"Artif Intell Gastrointest Endosc"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0685","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.3748\/wjg.v27.i31.5152","article-title":"Helicobacter pylori eradication: exploring its impacts on the gastric mucosa","volume":"27","author":"Weng","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0690","doi-asserted-by":"crossref","first-page":"36","DOI":"10.52787\/agl.v52i1.176","article-title":"M\u00e9todos diagn\u00f3sticos para la detecci\u00f3n de infecci\u00f3n por Helicobacter pylori. \u00bfCu\u00e1l y cu\u00e1ndo deben solicitarse?","volume":"52","author":"Chahuan","year":"2022","journal-title":"Acta Gastroenterol Latinoam"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0700","first-page":"330","article-title":"Tratamiento emp\u00edrico vs tratamiento basado en susceptibilidad para erradicar H. pylori: \u00bfEs posible cambiar este paradigma usando m\u00e9todos moleculares modernos?","volume":"87","author":"Garrido-Trevi\u00f1o","year":"2022","journal-title":"Rev Gastroenterol Mex"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0705","doi-asserted-by":"crossref","DOI":"10.3390\/healthcare12151479","article-title":"Comparison of four tests for the diagnosis of Helicobacter pylori infection","volume":"12","author":"Charach","year":"2024","journal-title":"Healthcare"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0715","article-title":"Doxycycline and minocycline in Helicobacter pylori treatment: a systematic review and meta-analysis","volume":"26","author":"Zhao","year":"2021","journal-title":"Helicobacter"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0720","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2174\/1389201023666220920094342","article-title":"Helicobacter pylori infection: conventional and molecular strategies for bacterial diagnosis and antibiotic resistance testing","volume":"24","author":"Ranjbar","year":"2023","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0725","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1541140","article-title":"Helicobacter pylori infection process: from the molecular world to clinical treatment","volume":"16","author":"Yi","year":"2025","journal-title":"Front Microbiol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0730","doi-asserted-by":"crossref","DOI":"10.1111\/hel.70007","article-title":"Advances in Helicobacter pylori antimicrobial resistance detection: from culture-based to multi-omics-based technologies","volume":"30","author":"Kuang","year":"2025","journal-title":"Helicobacter"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinsp.2022.100058","article-title":"Efficacy and safety of potassium-competitive acid blockers versus proton pump inhibitors as Helicobacter pylori eradication therapy: a meta-analysis of randomized clinical trials","volume":"77","author":"Zhang","year":"2022","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0740","first-page":"642","article-title":"The high-dose dual therapy for eradication of Helicobacter pylori: efficacy and safety","volume":"97","author":"Bakulina","year":"2025","journal-title":"Ter Arkh"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0745","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/S0140-6736(16)31409-X","article-title":"Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial","volume":"388","author":"Liou","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0750","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.gastro.2016.04.006","article-title":"The Toronto consensus for the treatment of Helicobacter pylori infection in adults","volume":"151","author":"Fallone","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0755","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12694","article-title":"Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: a real-life study","volume":"25","author":"Romano","year":"2020","journal-title":"Helicobacter"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0760","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12929-018-0471-z","article-title":"Toward population specific and personalized treatment of Helicobacter pylori infection","volume":"25","author":"Liou","year":"2018","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0765","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12977","article-title":"Efficacy of tegoprazan-based bismuth quadruple therapy compared with bismuth quadruple therapy for Helicobacter pylori infection: a randomized, double-blind, active-controlled study","volume":"28","author":"Kim","year":"2023","journal-title":"Helicobacter"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0770","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/apt.14319","article-title":"Systematic review with meta-analysis: the global recurrence rate of Helicobacter pylori","volume":"46","author":"Hu","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0775","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1053\/j.gastro.2020.11.059","article-title":"AGA clinical practice update on the management of refractory Helicobacter pylori infection: expert review","volume":"160","author":"Shah","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0780","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/jac\/dkae224","article-title":"Real-world efficacy of second-line therapies for Helicobacter pylori: a population-based study","volume":"79","author":"Guo","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0785","first-page":"330","article-title":"Empiric treatment vs susceptibility-guided treatment for eradicating H. pylori: is it possible to change that paradigm using modern molecular methods?","volume":"87","author":"Garrido-Trevi\u00f1o","year":"2022","journal-title":"Rev Gastroenterol Mex (Engl Ed)"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0790","first-page":"274","article-title":"Erradicaci\u00f3n de Helicobacter pylori en M\u00e9xico con un esquema basado en levofloxacina versus la triple terapia est\u00e1ndar: resultados de un estudio cl\u00ednico de fase iiib, abierto, aleatorizado, de no inferioridad","volume":"84","author":"Ladr\u00f3n-de-Guevara","year":"2019","journal-title":"Rev Gastroenterol Mex"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0795","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/jgh.14462","article-title":"Systematic review and network meta-analysis: Comparative effectiveness of therapies for second-line Helicobacter pylori eradication","volume":"34","author":"Yeo","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0800","doi-asserted-by":"crossref","first-page":"269","DOI":"10.14309\/ajg.0000000000002045","article-title":"Rates of antimicrobial resistance in Helicobacter pylori isolates from clinical trial patients across the US and Europe","volume":"118","author":"M\u00e9graud","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0805","article-title":"Diagnosis and treatment patterns among patients with newly diagnosed Helicobacter pylori infection in the United States 2016-2019","volume":"13","author":"Shah","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0810","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.gtc.2015.05.003","article-title":"How to effectively use bismuth quadruple therapy: the good, the bad, and the ugly","volume":"44","author":"Graham","year":"2015","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0815","first-page":"22","article-title":"Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies","author":"Gisbert","year":"2017","journal-title":"Helicobacter"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0820","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cgh.2021.03.026","article-title":"Primer for development of guidelines for Helicobacter pylori therapy using antimicrobial stewardship","volume":"20","author":"Graham","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0825","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12768","article-title":"The appropriate cutoff gastric pH value for Helicobacter pylori eradication with bismuth-based quadruple therapy","volume":"26","author":"Ke","year":"2021","journal-title":"Helicobacter"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0830","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3748\/wjg.v30.i9.1213","article-title":"Treatment of Helicobacter pylori with potassium competitive acid blockers: a systematic review and meta-analysis","volume":"30","author":"Kanu","year":"2024","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0835","first-page":"24","article-title":"Relative potency of proton-pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double-dose PPI","author":"Graham","year":"2019","journal-title":"Helicobacter"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0840","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/14787210.2025.2459722","article-title":"Comparison of tegoprazan and proton pump inhibitors for first-line Helicobacter pylori eradication: a systematic review with meta-analysis","volume":"23","author":"Cho","year":"2025","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0845","doi-asserted-by":"crossref","DOI":"10.1177\/17562848251314801","article-title":"The efficacy and safety of Vonoprazan and Tegoprazan in Helicobacter pylori eradication: a comprehensive systematic review and meta-analysis of randomized controlled trials","volume":"18","author":"Jin","year":"2025","journal-title":"Therap Adv Gastroenterol"},{"issue":"S8","key":"10.1016\/j.rgmxen.2025.12.001_bib0850","first-page":"817","article-title":"Efficacy of tegoprazan-based bismuth quadruple therapy compared with bismuth quadruple therapy for Helicobacter pylori infection: a real world evidence experience","volume":"12","author":"Remes-Troche","year":"2024","journal-title":"United Eur Gastroenterol J."},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0855","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00228-008-0576-5","article-title":"Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH","volume":"65","author":"Kirchheiner","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0860","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1136\/gut.43.2008.S56","article-title":"The life and death of Helicobacter pylori","volume":"43","author":"Scott","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0865","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1053\/j.gastro.2022.05.055","article-title":"Vonoprazan triple and dual therapy for Helicobacter pylori infection in the United States and Europe: randomized clinical trial","volume":"163","author":"Chey","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0875","doi-asserted-by":"crossref","DOI":"10.1002\/jgh3.70134","article-title":"Tegoprazan-containing versus proton pump inhibitor-containing therapy for first-line eradication of Helicobacter pylori: a meta-analysis of randomized controlled trials","volume":"9","author":"Simadibrata","year":"2025","journal-title":"JGH Open"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0880","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1056\/NEJMra1807761","article-title":"Penicillin allergy","volume":"381","author":"Castells","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0885","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12686","article-title":"Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: experience from the European Registry on H pylori management (Hp-EuReg)","volume":"25","author":"Nyssen","year":"2020","journal-title":"Helicobacter"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0890","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1365-2036.2005.02687.x","article-title":"Helicobacter pylori first-line treatment and rescue options in patients allergic to penicillin","volume":"22","author":"Gisbert","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0895","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.dld.2009.06.007","article-title":"Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin","volume":"42","author":"Gisbert","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0900","first-page":"22","article-title":"Vonoprazan improves the efficacy of Helicobacter pylori eradication therapy with a regimen consisting of clarithromycin and metronidazole in patients allergic to penicillin","author":"Ono","year":"2017","journal-title":"Helicobacter"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0905","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223309","article-title":"Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: a meta-analysis of randomized controlled trials","volume":"14","author":"Yu","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0910","doi-asserted-by":"crossref","DOI":"10.1111\/hel.70006","article-title":"Efficacy of Lactobacillus spp. supplementation in Helicobacter pylori eradication: a systematic meta-analysis of randomized controlled trials with trial sequential analysis","volume":"29","author":"Mishra","year":"2024","journal-title":"Helicobacter"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0915","article-title":"The effect of supplementing with Saccharomyces boulardii on bismuth quadruple therapy for eradicating Helicobacter pylori: a systematic review and meta-analysis of randomized controlled trials","volume":"30","author":"Chen","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0920","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223309","article-title":"Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: a meta-analysis of randomized controlled trials","volume":"14","author":"Yu","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0925","article-title":"Efficacy and safety of probiotics in eradicating Helicobacter pylori: a network meta-analysis","volume":"98","author":"Shi","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.rgmxen.2025.12.001_bib0935","article-title":"The effects of probiotics supplementation on Helicobacter pylori standard treatment: an umbrella review of systematic reviews with meta-analyses","volume":"14","author":"Yang","year":"2024","journal-title":"Sci Rep"}],"container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255534X25001641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255534X25001641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:01:30Z","timestamp":1779206490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2255534X25001641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":181,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2255534X25001641"],"URL":"https:\/\/doi.org\/10.1016\/j.rgmxen.2025.12.001","relation":{},"ISSN":["2255-534X"],"issn-type":[{"value":"2255-534X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Fifth Mexican consensus on the diagnosis and treatment of Helicobacter pylori infection","name":"articletitle","label":"Article Title"},{"value":"Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmxen.2025.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmx.2025.10.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}